PL2076502T3 - Podstawione karboksyamidy jako antagoniści receptorów metabotropowych grupy I - Google Patents
Podstawione karboksyamidy jako antagoniści receptorów metabotropowych grupy IInfo
- Publication number
- PL2076502T3 PL2076502T3 PL07873705T PL07873705T PL2076502T3 PL 2076502 T3 PL2076502 T3 PL 2076502T3 PL 07873705 T PL07873705 T PL 07873705T PL 07873705 T PL07873705 T PL 07873705T PL 2076502 T3 PL2076502 T3 PL 2076502T3
- Authority
- PL
- Poland
- Prior art keywords
- group
- receptor antagonists
- metabotropic receptor
- substituted carboxamides
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US81183906P | 2006-06-08 | 2006-06-08 | |
PCT/US2007/070572 WO2008103185A2 (en) | 2006-06-08 | 2007-06-07 | Substituted carboxamides as group i metabotropic receptor antagonists |
EP07873705A EP2076502B1 (en) | 2006-06-08 | 2007-06-07 | Substituted carboxamides as group i metabotropic receptor antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2076502T3 true PL2076502T3 (pl) | 2011-09-30 |
Family
ID=39673278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07873705T PL2076502T3 (pl) | 2006-06-08 | 2007-06-07 | Podstawione karboksyamidy jako antagoniści receptorów metabotropowych grupy I |
Country Status (31)
Country | Link |
---|---|
US (1) | US7960419B2 (pl) |
EP (1) | EP2076502B1 (pl) |
JP (1) | JP5108878B2 (pl) |
KR (1) | KR101051559B1 (pl) |
CN (1) | CN101466691B (pl) |
AT (1) | ATE509921T1 (pl) |
AU (1) | AU2007347428B2 (pl) |
BR (1) | BRPI0712862A2 (pl) |
CA (1) | CA2652074C (pl) |
CR (1) | CR10410A (pl) |
CY (1) | CY1111588T1 (pl) |
DK (1) | DK2076502T3 (pl) |
EA (1) | EA014233B1 (pl) |
EC (1) | ECSP088939A (pl) |
ES (1) | ES2362949T3 (pl) |
HK (1) | HK1131984A1 (pl) |
HR (1) | HRP20110436T1 (pl) |
IL (1) | IL195632A (pl) |
MA (1) | MA30620B1 (pl) |
MX (1) | MX2008015485A (pl) |
MY (1) | MY148084A (pl) |
NO (1) | NO341474B1 (pl) |
NZ (1) | NZ573352A (pl) |
PL (1) | PL2076502T3 (pl) |
PT (1) | PT2076502E (pl) |
RS (1) | RS51818B (pl) |
SI (1) | SI2076502T1 (pl) |
TN (1) | TNSN08506A1 (pl) |
UA (1) | UA95480C2 (pl) |
WO (1) | WO2008103185A2 (pl) |
ZA (1) | ZA200809111B (pl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0804685D0 (en) | 2008-03-13 | 2008-04-16 | Univ Edinburgh | Therapeutic compounds and their use |
TW200944522A (en) | 2008-04-04 | 2009-11-01 | Lilly Co Eli | 3-indazolyl-4-pyridylisothiazoles |
WO2010146338A1 (en) * | 2009-06-15 | 2010-12-23 | The University Of Edinburgh | Amido-isothiazole compounds and their use as inhibitors of 11beta-hsd1 for the treatment of metabolic syndrome and related disorders |
EP2477983B1 (en) | 2009-09-16 | 2015-04-15 | The University Of Edinburgh | (4-phenyl-piperidin-1-yl)-[5-1h-pyrazol-4yl)-thiophen-3-yl]-methanone compounds and their use |
DK2563780T3 (en) | 2010-04-29 | 2015-07-27 | Univ Edinburgh | 3,3-DISUBSTITUEREDE- (8-aza-bicyclo [3.2.1] oct-8-yl) - [5- (1H-pyrazol-4-yl) -thiophene-3-yl] -METHANONER as inhibitors of 11 ( BETA) -HSD1 |
WO2014077235A1 (ja) | 2012-11-13 | 2014-05-22 | 大正製薬株式会社 | 2-ピリドン化合物 |
CA3037642A1 (en) | 2016-09-23 | 2018-03-29 | Bayer Aktiengesellschaft | N 3 -cyclically substituted thienouraciles and use thereof |
CN117567266A (zh) * | 2023-11-07 | 2024-02-20 | 康龙化成手性医药技术(宁波)有限公司 | 一种制备2-甲基环丙羧酸的方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL72091A0 (en) * | 1983-06-20 | 1984-10-31 | Lilly Co Eli | N'-substituted(3-aryl 5-isothiazolyl)urea derivatives |
DE4328425A1 (de) * | 1993-08-24 | 1995-03-02 | Basf Ag | Acylamino-substituierte Isoxazol- bzw. Isothiazolderivate, Verfahren zu deren Herstellung und ihre Verwendung |
DK124393D0 (da) * | 1993-11-03 | 1993-11-03 | Lundbeck & Co As H | Compounds |
DE19542372A1 (de) * | 1995-11-14 | 1997-05-15 | Bayer Ag | Acylierte 5-Aminoisothiazole |
UA60365C2 (uk) * | 1998-06-04 | 2003-10-15 | Пфайзер Продактс Інк. | Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця |
JP3411262B2 (ja) * | 1999-08-20 | 2003-05-26 | 萬有製薬株式会社 | 新規スピロ化合物 |
MXPA04000920A (es) * | 2001-08-06 | 2004-04-02 | Pharmacia Italia Spa | Derivados de aminoisoxazol activos como inhibidores de la cinasa. |
WO2005030128A2 (en) * | 2003-09-23 | 2005-04-07 | Merck & Co., Inc. | Pyrazole modulators of metabotropic glutamate receptors |
JP2007537272A (ja) * | 2004-05-12 | 2007-12-20 | シェーリング コーポレイション | Cxcr1およびcxcr2ケモカインアンタゴニスト |
BRPI0515571A (pt) * | 2004-09-23 | 2008-07-29 | Pfizer Prod Inc | agonistas de receptor de trombopoetina |
-
2007
- 2007-06-07 PL PL07873705T patent/PL2076502T3/pl unknown
- 2007-06-07 NZ NZ573352A patent/NZ573352A/en not_active IP Right Cessation
- 2007-06-07 PT PT07873705T patent/PT2076502E/pt unknown
- 2007-06-07 WO PCT/US2007/070572 patent/WO2008103185A2/en active Application Filing
- 2007-06-07 EP EP07873705A patent/EP2076502B1/en active Active
- 2007-06-07 CN CN2007800211890A patent/CN101466691B/zh not_active Expired - Fee Related
- 2007-06-07 KR KR1020087029772A patent/KR101051559B1/ko not_active IP Right Cessation
- 2007-06-07 MX MX2008015485A patent/MX2008015485A/es active IP Right Grant
- 2007-06-07 AU AU2007347428A patent/AU2007347428B2/en not_active Ceased
- 2007-06-07 EA EA200870516A patent/EA014233B1/ru not_active IP Right Cessation
- 2007-06-07 AT AT07873705T patent/ATE509921T1/de active
- 2007-06-07 JP JP2009514523A patent/JP5108878B2/ja not_active Expired - Fee Related
- 2007-06-07 UA UAA200813907A patent/UA95480C2/uk unknown
- 2007-06-07 MY MYPI20084973A patent/MY148084A/en unknown
- 2007-06-07 SI SI200730695T patent/SI2076502T1/sl unknown
- 2007-06-07 CA CA2652074A patent/CA2652074C/en not_active Expired - Fee Related
- 2007-06-07 ES ES07873705T patent/ES2362949T3/es active Active
- 2007-06-07 RS RS20110336A patent/RS51818B/en unknown
- 2007-06-07 US US12/300,415 patent/US7960419B2/en active Active
- 2007-06-07 DK DK07873705.3T patent/DK2076502T3/da active
- 2007-06-07 BR BRPI0712862-2A patent/BRPI0712862A2/pt not_active IP Right Cessation
- 2007-10-29 CR CR10410A patent/CR10410A/es unknown
-
2008
- 2008-10-23 ZA ZA200809111A patent/ZA200809111B/xx unknown
- 2008-12-01 IL IL195632A patent/IL195632A/en not_active IP Right Cessation
- 2008-12-02 NO NO20085028A patent/NO341474B1/no not_active IP Right Cessation
- 2008-12-03 EC EC2008008939A patent/ECSP088939A/es unknown
- 2008-12-05 TN TNP2008000506A patent/TNSN08506A1/en unknown
-
2009
- 2009-01-06 MA MA31553A patent/MA30620B1/fr unknown
- 2009-12-02 HK HK09111272.7A patent/HK1131984A1/xx not_active IP Right Cessation
-
2011
- 2011-06-09 HR HR20110436T patent/HRP20110436T1/hr unknown
- 2011-06-24 CY CY20111100600T patent/CY1111588T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1131984A1 (en) | Substituted carboxamides as group i metabotropic receptor antagonists | |
IL184932A0 (en) | Glucagon receptor antagonists, preperation and therapeutic uses | |
WO2007106181A3 (en) | Glucagon receptor antagonists, preparation and therapeutic uses | |
SI1735278T1 (sl) | Agenti histamin h receptorja priprava in terapevtska uporaba | |
SI1957484T1 (sl) | Antagonisti glukagonskega receptorja, priprava in terapevtske uporabe | |
MX361542B (es) | Compuestos de morfinan. | |
UA86621C2 (ru) | Антагонисты рецептора глюкагона, их получение и терапевтическое применение | |
UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
UA92670C2 (ru) | Пиразолиновые соединения и их фармацевтическое применение, композиция на их основе | |
MY154591A (en) | Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor | |
MX2010002584A (es) | Derivados de piperidina como agonistas de receptores muscarinicos. | |
MX2012001160A (es) | Agonistas del receptor de esfingosina-1-fosfato. | |
MX2010009395A (es) | Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y procesos para preparacion de los mismos. | |
PT1861360E (pt) | Derivados de pirrolidina como antagonistas de receptores h3 de histamina | |
TW200806321A (en) | New therapeutic combinations for the treatment or prevention of psychotic disorders | |
PL1805169T3 (pl) | Inhibitory receptora histaminowego H3, ich wytwarzanie i zastosowania terapeutyczne | |
WO2007145563A8 (en) | Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor | |
EA015500B9 (ru) | Новые антагонисты мсн рецепторов |